A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12

Annals of the New York Academy of Sciences

Volumn 795, Issue , 1996, Pages 158-167

  Angiolillo, Anne L ^a   Sgadari, Cecilia ^b   Tosato, Giovanna ^b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; ANGIOSTATIN; ANTIBODY; FUMAGILLIN; FUMAGILLOL CHLOROACETYLCARBAMATE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTAMINE; PROTEIN; THROMBOCYTE FACTOR 4; THROMBOSPONDIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; B LYMPHOCYTE; BURKITT LYMPHOMA; CANCER CELL CULTURE; CELL IMMORTALIZATION; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUDE MOUSE; TISSUE NECROSIS; TUMOR REGRESSION;

EID: 0030475607     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb52664.x     Document Type: Conference Paper

References (32)

1. FOLKMAN, J. & Y. SHING. 1992. Angiogenesis. J. Biol. Chem. 267(16): 10931-10934.
2. FOLKMAN, J. 1992. The role of angiogenesis in tumor growth. Cancer Biol. 3: 65-71.
3. MULLER, G., J. BEHRENS, U. NUSSBAUMER, P. BOHLEN & W. BIRCHMEIER. 1987. Inhibitory action of transforming growth factor β on endothelial cells. Proc. Natl. Acad. Sci. 84: 5600-5604.
4. GOOD, D. J., P. POLVERINI, F. RASTINEJAD, et al. 1990. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. 87: 6624-6628.
5. COZZOLINO, F., M. TORCIA, D. ALDINUCCI, et al. 1990. Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc. Natl. Acad. Sci. 87: 6487-6491.
6. FRIESEL, R., A. KOMORIYA & T. MACIAG. 1987. Inhibition of endothelial cell proliferation by gamma-interferon. J. Cell Biol. 104: 689-696.
7. TAKIGAWA, M., Y. NISHIDA, F. SUZUKI, J. KISHI, K. YAMASHITA & T. HAYAKAWA. 1990. Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2). Biochem. Biophys. Res. Commun. 171(3): 1264-1271.
8. MAIONE, T., G. GRAY, J. PETRO, et al. 1990. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247: 77-79.
9. TAYLOR, S. & J. FOLMAN. 1982. Protamine is an inhibitor of angiogenesis. Nature 297: 307-312.
10. KIM, K., B. LI, J. WINER, et al. 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362: 841-844.
11. INGBER, D., T. FUJITA, S. KISHIMOTO, et al. 1990. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 348: 555-557.
12. MOSES, M., J. SUDHALTER & R. LANGER. 1990. Identification of an inhibitor of neovascularization from cartilage. Science 248: 1408-1410.
13. O'REILLY, M., L. HOLMGREN, Y. SING, et al. 1994. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by Lewis lung carcinoma. Cell 79: 315-328.
14. TOSATO, G., C. SGADARI, K. TAGA, et al. 1994. Regression of experimental Burkitt's lymphoma induced by Epstein-Barr virus-immortalized human B cells. Blood 83(3): 776-784.
15. GURTSEVITCH, V. E., G. T. O'CONOR & G. M. LENOIR. 1988. Burkitt's lymphoma cell lines reveal different degrees of tumorigenicity in nude mice. Intl. J. Cancer 41: 87-95.
16. NILSSON, K., B. GIOVANELLA, J. STEHLIN & G. KLEIN. 1977. Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Intl. J. Cancer 19: 337-344.
17. WALTER, J., P. MILLER, G. MOLDENHAUER, V. SHIRRMACHER, M. PAWLITA & J. WOLF. 1992. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic hybrids in SCID mice. Intl. J. Cancer 50: 265-273.
18. ANGIOLILLO, A., C. SGADARI, N. SHEIKH, G. REAMAN & G. TOSATO. 1995. Regression of experimental human leukemias and solid tumors induced by Epstein-Barr virusimmortalized B cells. Leuk. Lymph. 19: 267-276.
19. LUSTER, A., J. UNKELESS& J. RAVETCH. 1985. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315: 672-676.
20. LUSTER, A. & J. RAVETCH. 1987. Biochemical characterization of a γ interferoninducible cytokine (IP-10). J. Exp. Med. 166: 1084-1097.
21. VANGURI, P. & J. FARBER. 1990. Identification of CRG-2, an interferon-inducible mRNA predicted to encode a murine monokine. J. Biol. Chem. 265(25): 15049-15057.
22. SARRIS, A., H. BROXMEYER, U. WIRTHMUELLER, et al. 1993. Human interferon-inducible protein 10: Expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors. J. Exp. Med. 178: 1127-1132.
23. LUSTER, A. & P. LEDER. 1993. IP-10, a -C-X-C chemokine, elicits a potent thymus-dependent antitumor response in vivo. J. Exp. Med. 178: 1057-1065.
24. TAUB, D., A. LLOYD, K. CONLON, et al. 1993. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177: 1809-1814.
25. FARBER, J. 1993. HuMig: A new human member of the chemokine family of cytokines. Biochem. Biophys. Res. Commun. 192(1): 223-230.
26. LIAO, F., R. RABIN, J. YANNELLI, L. KONIARIS, P. VANGURI & J. FARBER. 1995. Human Mig chemokine: Biochemical and functional characterization. J. Exp. Med. 182: 1301-1314.
27. LUSTER, A., S. GREENBERG & P. LEDER. 1995. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med. 182: 219-231.
28. KLEINMAN, H., M. MCGARVEY, J. HASSELL, et al. 1986. Basement membrane complexes with biological activity. Biochemistry 25(2): 312-318.
29. PASSANITI, A., R. TAYLOR, R. PILI, et al. 1992. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Methods Lab. Invest. 67(4): 519-528.
30. ANGIOLILLO, A., C. SGADARI, D. TAUB, et al. 1995. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182: 155-162.
31. VOEST, E., B. KENYON, M. O'REILLY, G. TRUITT, R. D'AMATO & J. FOLKMAN. 1995. Inhibition of angiogenesis in vivo by interleukin 12. J. Natl. Cancer Inst. 87(8): 581-586.
32. NASTALA, C., H. EDINGTON, T. MCKINNEY, et al. 1994. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153: 1697-1705.